Según un estudio realizado en la costa vizcaína, las especies de algas de afinidad fría están siendo reemplazadas gradualmente por especies de afinidad cálida
Read moreWith enhancements to performance, user experience and energy efficiency, the Thermo Scientific™ TSX™ Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of l...
Read moreA team of experts from the European consortium LIVERSCREEN, led by IDIBAPS and funded through the Horizon 2020 programme, used their expertise and all they learnt in the colorectal and lung cancer scr...
Read moreThe use of artificial intelligence (AI) in healthcare has significantly revolutionized the industry. With its ability to process vast amounts of data, AI has the potential to transform patient care by...
Read moreCIC biomaGUNE matures a business project in order to market innovative devices designed to detect respiratory diseases in self-test format
Read moreI has been developed micromaterials made up only of proteins, capable of delivering over an extended period of time nanoparticles that attack specific cancer cells and destroy them. The micromaterials...
Read moreA clinical trial with the prototype of the device shows that the use of this technology improves patient monitoring by nurses and reduces post-surgical complications.
Read moreSpinally Medical introduces FuturaLead™, a subarachnoid device for spinal cord stimulation aimed at patients suffering from chronic pain.
Read moreUn ensayo clínico financiado por los Institutos Nacionales de Salud de EE.UU. podría conducir al primer tratamiento eficaz para la enfermedad de calcificación arterial por deficiencia de CD73 .
Read moreEl centro es el primero en España en aplicar esta técnica a pacientes pediátricos con cardiopatías congénitas, que debían ser intervenidos mediante cirugía abierta.
Read moreInvestigadores de la Universidad Politécnica de Madrid han desarrollado MONIPAR, una nueva herramienta que permite el seguimiento de síntomas motores de párkinson usando teléfonos y relojes inteli...
Read moreOryzon Genomics announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to initiate a Phase I/II trial with iadademstat plus immune...
Read more